CN
88-13-1
应用筛选条件
关键词:'88-13-1'
显示 1-30 共 543 条结果 关于 "88-13-1" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
92 86 100 87 75 106 81 25 109 95 101 6 32 18
GSK-3β 107 92 90 13 38 105 83 101 66 61 85 53 30 89 58 99 5 50 46
ROCK-II 0 13 7
The Effective Use of Protein Kinase Inhibitors
92 86 100 87 75 106 81 25 109 95 101 6 32 18
GSK-3β 107 92 90 13 38 105 83 101 66 61 85 53 30 89 58 99 5 50 46
ROCK-II 0 13 7
Poster - PVA as binder in continuous twin-screw granulation
Mannitol (Pearlitol
50C, Roquette, Lestrem) as hydrophilic filler. Different
grades of PVA (4-88, 18-88, 40-88, MilliporeSigma,
Germany) were used as binder, 5% w/w was added
to the filler. Additionally
Polyvinyl alcohol: Revival of a long lost polymer
25%
PVA 18–88 ✓ ✓ 18%
PVA 26–88 ✓ ✓ 15%
PVA 40–88 ✓ ✓ 13%
PVA 28–99 ✓ ✓ 15%
* Maximum solubility was defined as the concentration at which the mixture exceeded
Product Information Sheet - CS0710
Solution
Lysis Buffer Reaction Mixture
Test X µl --- --- 88-X µl 12 µl
Blank --- --- --- 88 µl 12 µl
Modulator Reaction X µl --- Y µl 88-X-Y µl 12 µl
Data Sheet - E8279
).
16. O′Reilly, M.S., et al., Cell, 88, 277-285 (1997).
17. Dixelius, J., et al., Cancer Res., 62, 1944-1947
(2002).
18. Miosge, M., et al., FASEB J., 13, 1743-1750
(1999).
19. Dhanabal M, et
Data Sheet - E8154
(2000).
16. O’Reilly, M.S. et al., Cell, 88, 277-285 (1997).
17. Dixelius, J. et al., Cancer Res., 62, 1944-1947
(2002).
18. Miosge, M. et al., FASEB J., 13, 1743-1750 (1999).
19. Dhanabal, M. et al
Data Sheet - E1783
al., Brain Res., 1228, 6-13
(2008).
8. Chen, G. et al., Proteomics, 3, 496-504 (2003).
9. Balabanov, S. et al., Blood, 109, 1701-1711 (2007).
VS,DS,KAA,PHC,MAM 06/19-1
2019
Verfication summary-03-0202-00
.0 8% 88%
3 1:32 5.75 0.9 16% 184.09 29.3 16% 102%
HMN713788
3 MRD (1:4) 21.56 3.2 15% 86.25 12.6 15% -
3 1:8 11.27 0.4 4% 90.12 3.3 4% 104%
3 1:16 5.95 1.1
Verfication summary-03-0202-00
.0 8% 88%
3 1:32 5.75 0.9 16% 184.09 29.3 16% 102%
HMN713788
3 MRD (1:4) 21.56 3.2 15% 86.25 12.6 15% -
3 1:8 11.27 0.4 4% 90.12 3.3 4% 104%
3 1:16 5.95 1.1
Data Sheet - G5419
(1996).
9. Karlsen, A.E., et al., Proc. Natl. Acad. Sci., 88,
8337 (1991).
10. Michelsen, B.K., et al., Proc. Natl. Acad. Sci., 88,
8754 (1991).
11. Kaufman, D.L., et al., J. Neurochem., 56
Data Sheet - F0550
1988).
8. Rothwell, V. M., and Rohrschneider, L. R.,
Oncogene Res., 1, 311-324 (1987).
9. Chabot, B., et al., Nature, 335, 88-89 (1988).
10. Geissler, E. N., et al., Cell, 55, 185-192 (1988).
11
App Note: Analysis of Drugs of Abuse in Urine After Cleanup with New Supel™ Swift HLB Solid Phase Extraction 96-well Plates
12 Buprenorphine
44%
5.8%
13 Methadone
90%
2.7%
Overall*
88%
10.8
5
Figure 7. Matrix effects (ion suppression and ion enhancement) Across the 13 analytes. Purple dash lines Represent
PTFE Membrane Filters - For filtering acids, bases, or solvents, as well as gases
70 10 13 14
EASTERN EUROPE,
C.I.S., AFRICA, MIDDLE
EAST AND GULF
Life Sciences Division:
Tel. +33 3 88 38 9536
Fax +33 3 88 38 9539
BioPharmaceutical Division:
Tel. +43 1 877-8926
Fax +43 1 877-1654
Protocol: Human Ghrelin (Active)
Recovery rate
1
0 (Basal) 325 -- 239 --
100 416 91% 338 99%
1,000 1,203
Data Sheet - SCC324
Contamination: Negative
• STR Profile: Pass
Figure 1. Patient derived organoid morphology.
Duodenum Intestinal Organoids, Age 33 (Prep 88-D) after
expansion at passage 5.
Data Sheet - SCC323
Mycoplasma Contamination: Negative
• STR Profile: Pass
Figure 1. Patient derived organoid morphology. Colon
Intestinal Organoids, Age 33 (Prep 88-C) after expansion
at passage 5.
Data Sheet - G1166
(1996).
9. Karlsen, A.E., et al., Proc. Natl. Acad. Sci., 88,
8337 (1991).
10. Michelsen, B.K., et al., Proc. Natl. Acad. Sci., 88,
8754 (1991).
11. Kaufman, D.L. et al., J. Neurochem., 56
Data Sheet - T2440
, et al., Immunology, 88, 284 (1996).
5. de Rochemonteix, B.G., et al., Am. J. Respir. Cell
Mol. Biol., 14, 279 (1996).
6. Lewis, M., et al., Proc. Natl. Acad. Sci. USA, 88,
2830
Data Sheet - T1815
, et al., Immunology, 88, 284 (1996).
5. de Rochemonteix, B.G., et al., Am. J. Respir. Cell
Mol. Biol., 14, 279 (1996).
6. Lewis, M., et al., Proc. Natl. Acad. Sci. USA, 88,
2830
Product Information Sheet - MD0100
Reaction
mix
Test X µl --- 88-X µl 12 µl
Blank --- --- 88 µl 12 µl
Positive
Control --- 2 µl 86 µl 12 µl
X is the volume of cell lysate
QC Range Sheet MCKP1-110K
Granzyme B Control 1 88 - 184 pg/mL IL-10 Control1 93- 192 pg/ml
Control 2 369 - 766 pg/mL Control 2 375 - 779 pg/ml
LABORATORY NOTEBOOK ISSUANCE PAGE
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
Lab Notebook Guidelines
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
Data Sheet - T2190
Crit. Rev. Immunol., 16
(1), 1 (1996).
18. Lewis, M., et al., Proc. Natl. Acad. Sci. USA, 88,
2830 (1991).
19. Ashkenazi, A., et al., Proc. Natl. Acad. Sci. USA,
88, 10535 (1991).
20. Tartaglia
Quality Control Range Sheet- MCC-115 and MCC-215
Control 1 87 - 181 pg/mL MCP-1 Control 1 95 - 197 pg/mL
Control 2 485 - 1008 pg/mL Control 2 419 - 870 pg/mL Control 2 522 - 1083 pg/mL
Quality Control Range Sheet- A60MG-105 and A60MG-205
8759 pg/ml
IL-4 Control 1 21 - 44 pg/mL IL-18 Control1 18 - 37 pg/ml
Control 2 103 - 214 pg/mL Control 2
LABORATORY NOTEBOOK ISSUANCE PAGE
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
LABORATORY NOTEBOOK ISSUANCE PAGE
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
Pellicon® Single-Pass TFF Accessories Installation and User Guide
Installation and User Guide 13
Installation
Components
Key Description
1 Holder end plate
2 Gasket
3 Pellicon® Single-Pass TFF Mini diverter plate
4 Pellicon® 3 88 cm2 or 0.11 m2 Cassette
5 Tie
1/19